BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

505 related articles for article (PubMed ID: 2455193)

  • 1. Effects of antihypertensive drugs on sympathetic vascular control in relation to neuropeptide Y.
    Lundberg JM; Pernow J; Franco-Cereceda A; Rudehill A
    J Cardiovasc Pharmacol; 1987; 10 Suppl 12():S51-68. PubMed ID: 2455193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-adrenergic, non-cholinergic vascular control with reference to neuropeptide Y, vasoactive intestinal polypeptide and nitric oxide.
    Modin A
    Acta Physiol Scand Suppl; 1994; 622():1-74. PubMed ID: 7524267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-release and functional interactions of neuropeptide Y and noradrenaline in peripheral sympathetic vascular control.
    Pernow J
    Acta Physiol Scand Suppl; 1988; 568():1-56. PubMed ID: 3232527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulatory interactions of neuropeptide Y (NPY) on sympathetic neurotransmission.
    Linton-Dahlöf P
    Acta Physiol Scand Suppl; 1989; 586():1-85. PubMed ID: 2557726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adrenergic and non-adrenergic mechanisms in sympathetic vascular control of the nasal mucosa.
    Lacroix JS
    Acta Physiol Scand Suppl; 1989; 581():1-63. PubMed ID: 2568728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropeptide Y Y1 receptor mechanisms in sympathetic vascular control.
    Malmström RE
    Acta Physiol Scand Suppl; 1997; 636():1-55. PubMed ID: 9179320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sympathetic vascular control of the pig nasal mucosa (III): Co-release of noradrenaline and neuropeptide Y.
    Lacroix JS; Stjärne P; Anggärd A; Lundberg JM
    Acta Physiol Scand; 1989 Jan; 135(1):17-28. PubMed ID: 2911948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms underlying pre- and postjunctional effects of neuropeptide Y in sympathetic vascular control.
    Pernow J; Saria A; Lundberg JM
    Acta Physiol Scand; 1986 Feb; 126(2):239-49. PubMed ID: 3010640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Release and vasoconstrictor effects of neuropeptide Y in relation to non-adrenergic sympathetic control of renal blood flow in the pig.
    Pernow J; Lundberg JM
    Acta Physiol Scand; 1989 Aug; 136(4):507-17. PubMed ID: 2571235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Neuropeptide Y, orthosympathetic nervous system, hypertension and alpha-2 adrenergic receptors].
    Poncet MF; Tavernier G; Damase-Michel C; Tran MA; Berlan M; Montastruc JL; Montastruc P
    Arch Mal Coeur Vaiss; 1991 Aug; 84(8):1239-41. PubMed ID: 1659347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prejunctional adrenergic receptors and sympathetic neurotransmission: studies in canine skeletal muscle vasculature in situ.
    Kahan T
    Acta Physiol Scand Suppl; 1987; 560():1-38. PubMed ID: 2884804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the neuropeptide Y Y2 receptor antagonist BIIE0246 on sympathetic transmitter release in the pig in vivo.
    Malmström RE; Lundberg JN; Weitzberg E
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Feb; 365(2):106-11. PubMed ID: 11819028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possible involvement of neuropeptide Y in sympathetic vascular control of canine skeletal muscle.
    Pernow J; Kahan T; Hjemdahl P; Lundberg JM
    Acta Physiol Scand; 1988 Jan; 132(1):43-50. PubMed ID: 2906210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence against differential release of noradrenaline, neuropeptide Y, and dopamine-beta-hydroxylase from adrenergic nerves in the isolated perfused sheep spleen.
    De Potter WP; Kurzawa R; Miserez B; Coen EP
    Synapse; 1995 Feb; 19(2):67-76. PubMed ID: 7725244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms underlying changes in the contents of neuropeptide Y in cardiovascular nerves and adrenal gland induced by sympatholytic drugs.
    Lundberg JM; Saria A; Franco-Cereceda A; Theodorsson-Norheim E
    Acta Physiol Scand; 1985 Aug; 124(4):603-11. PubMed ID: 3840321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropeptide Y is released from human mammary and radial vascular biopsies and is a functional modulator of sympathetic cotransmission.
    Donoso MV; Miranda R; Irarrázaval MJ; Huidobro-Toro JP
    J Vasc Res; 2004; 41(5):387-99. PubMed ID: 15377822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BIBP 3226, suramin and prazosin identify neuropeptide Y, adenosine 5'-triphosphate and noradrenaline as sympathetic cotransmitters in the rat arterial mesenteric bed.
    Donoso MV; Steiner M; Huidobro-Toro JP
    J Pharmacol Exp Ther; 1997 Aug; 282(2):691-8. PubMed ID: 9262332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacology of noradrenaline and neuropeptide tyrosine (NPY)-mediated sympathetic cotransmission.
    Lundberg JM; Franco-Cereceda A; Hemsén A; Lacroix JS; Pernow J
    Fundam Clin Pharmacol; 1990; 4(4):373-91. PubMed ID: 2170253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropeptide Y-induced potentiation of noradrenergic vasoconstriction in the human saphenous vein: involvement of endothelium generated thromboxane.
    Fabi F; Argiolas L; Ruvolo G; del Basso P
    Br J Pharmacol; 1998 May; 124(1):101-10. PubMed ID: 9630349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The neuropeptide Y (NPY) Y1 receptor antagonist BIBP 3226: equal effects on vascular responses to exogenous and endogenous NPY in the pig in vivo.
    Malmström RE; Balmér KC; Lundberg JM
    Br J Pharmacol; 1997 Jun; 121(3):595-603. PubMed ID: 9179405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.